Please Wait...

Steve Goldstein

Translation skills

Main profile

Steve Goldstein
Director Study QC, IRT

Mr. Goldstein has over 20 years of regulated systems experience, which includes 13 focused on clinical IRT primarily for a clinical packaging and distribution vendor.  Mr. Goldstein brings a clinical supplies perspective to IRT systems that complements the clinical perspective employed on most IRT teams.  Mr. Goldstein joined BioClinica in 2009, and his current responsibilities include managing the Study QC team. He holds responsibility for study-specific testing, validation, and QC activities of BioClinica's EDC and IRT systems.  Mr. Goldstein received a B.A. in Chemistry from Cornell University and a M.S. in Chemical Engineering from Georgia Tech.

Blogs

With the increasing complexity in protocols and need to increase the cost-effectiveness of studies, your IRT-related decisions play an even greater role in ensuring the most appropriate patient randomization and clinical supply strategies. Gone are the days of being able to use the "tried and true" IRT systems without further consideration of if they meet your protocol requirements.

In the last blog we talked about how technology transfer is gaining ground on the conventional Software as a Service (SaaS) IRT sourcing model. In this blog post, I will explain the advantages of the technology and design behind Trident that make it particularly well-suited for IRT technology transfer. So let's dive right in.

When it comes to Interactive Response Technology (IRT) – systems used to perform subject randomization, drug dispensing and study drug resupply – Software as a Service (SaaS) continues to be the conventional delivery model including here at BioClinica.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Thanks everyone who joined us in today's webinar! https://t.co/Wp6D0oLfc3
Bioclinica (1 hour ago)
Kicking off at 11 EST!! https://t.co/v4hMLK9oAZ
Bioclinica (3 hours ago)
BREAKING: Bioclinica Launches NAFLD/NASH Clinical Trials Practice. Helps sponsors apply medical imaging in trials t… https://t.co/JLTxoevbXU
Bioclinica (6 hours ago)
BREAKING: Bioclinica launches #NAFLD #NASH clinical trials practice, helping sponsors apply medical imaging in tria… https://t.co/eUy34LiSAd
Bioclinica (8 hours ago)
Attending the #NASH Summit next week? If so, drop by @bioclinica's exhibit to learn how medical imaging is being u… https://t.co/TNkl7ce4Sq
Bioclinica (Yesterday)
RT @bioclinica: Sponsors conducting clinical trials in #NAFLD or #NASH are invited to join us in an upcoming webinar exploring the use of n…
Bioclinica (Yesterday)

Latest Blogs:

Site Payments Solutions
Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box